← Leaderboards
Joshua Anthony Lile
University Of Kentucky
$8,940,358
Attributed
$13,049,973
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$13,049,973 · 10
By mechanism
R01$11,555,219 · 5
K01$729,264 · 1
K02$487,340 · 1
M01$212,890 · 2
F31$65,260 · 1
Top collaborators
- Joshua Beckmann10 shared
- Michael J Wesley10 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Sharon L. Walsh$101,480,172
- Craig R Rush$27,535,139
- Shanna Babalonis$4,991,850
- Joshua Beckmann$3,058,120
- Michael J Wesley$2,846,833
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsProceduresInnovationFutureReinforcerEnvironmentSelf AdministrationDrug UsageMaintenanceBasePharmacotherapyDependenceCuesPsychological ReinforcementSafetyBehavioralScheduleDrug Of AbuseGamma-Aminobutyric AcidClinical TrialsCannabisPharmacological TreatmentIllicit DrugsDose
Grant awards (37)
A Translational Determination of the Mechanisms of Maladaptive Choice in Opioid Use Disorder$616,839
R01 · FY2023 · DA · contact PI
A Translational Determination of the Mechanisms of Maladaptive Choice in Opioid Use Disorder$625,139
R01 · FY2022 · DA · contact PI
A translational determination of the mechanisms of maladaptive choice in cocaine use disorder$604,599
R01 · FY2022 · DA · contact PI
A Translational Determination of the Mechanisms of Maladaptive Choice in Opioid Use Disorder$648,345
R01 · FY2021 · DA · contact PI
A translational determination of the mechanisms of maladaptive choice in cocaine use disorder$617,474
R01 · FY2021 · DA · contact PI
A translational determination of the mechanisms of maladaptive choice in cocaine use disorder$632,052
R01 · FY2020 · DA · contact PI
A Translational Determination of the Mechanisms of Maladaptive Choice in Opioid Use Disorder$620,393
R01 · FY2020 · DA · contact PI
A Translational Determination of the Mechanisms of Maladaptive Choice in Opioid Use Disorder$620,948
R01 · FY2019 · DA · contact PI
A translational determination of the mechanisms of maladaptive choice in cocaine use disorder$592,044
R01 · FY2019 · DA · contact PI
Human Laboratory Screening of Pregabalin and Tiagabine for Cannabis Dependence$444,994
R01 · FY2019 · DA · contact PI
A translational determination of the mechanisms of maladaptive choice in cocaine use disorder$586,590
R01 · FY2018 · DA · contact PI
Human Laboratory Screening of Pregabalin and Tiagabine for Cannabis Dependence$446,808
R01 · FY2018 · DA · contact PI
Human Laboratory Screening of Pregabalin and Tiagabine for Cannabis Dependence$442,520
R01 · FY2017 · DA · contact PI
Medications Development for Cocaine: A Translational Approach in Monkey and Human$443,275
R01 · FY2016 · DA · contact PI
Medications Development for Cocaine: A Translational Approach in Monkey and Human$570,260
R01 · FY2015 · DA · contact PI
Human Laboratory Screening of Pregabalin and Tiagabine for Cannabis Dependence$382,610
R01 · FY2015 · DA · contact PI
Medications Development for Cannabis-Use Disorders: Clinical Studies$97,468
K02 · FY2015 · DA · contact PI
Medications Development for Cocaine: A Translational Approach in Monkey and Human$557,759
R01 · FY2014 · DA · contact PI
Human Laboratory Screening of Pregabalin and Tiagabine for Cannabis Dependence$371,132
R01 · FY2014 · DA · contact PI
Medications Development for Cannabis-Use Disorders: Clinical Studies$97,468
K02 · FY2014 · DA · contact PI
Medications Development for Cocaine: A Translational Approach in Monkey and Human$284,640
R01 · FY2013 · DA · contact PI
Medications Development for Cannabis-Use Disorders: Clinical Studies$97,468
K02 · FY2013 · DA · contact PI
Medications Development for Cannabis-Use Disorders: Clinical Studies$97,468
K02 · FY2012 · DA · contact PI
GABA Drugs for Cannabis-Use Disorders: Initial Mechanistic Studies in Humans$351,710
R01 · FY2011 · DA · contact PI
Medications Development for Cannabis-Use Disorders: Clinical Studies$97,468
K02 · FY2011 · DA · contact PI
GABA Drugs for Cannabis-Use Disorders: Initial Mechanistic Studies in Humans$362,588
R01 · FY2010 · DA · contact PI
GABA Drugs for Cannabis-Use Disorders: Initial Mechanistic Studies in Humans$366,250
R01 · FY2009 · DA · contact PI
A Pharmacological Analysis of Delta 9-THC in Humans$152,141
K01 · FY2009 · DA · contact PI
GABA Drugs for Cannabis-Use Disorders: Initial Mechanistic Studies in Humans$366,250
R01 · FY2008 · DA · contact PI
A Pharmacological Analysis of Delta 9-THC in Humans$148,209
K01 · FY2008 · DA · contact PI
A Pharmacological Analysis of Delta 9-THC in Humans$148,433
K01 · FY2007 · DA · contact PI
A PHARMACOLOGICAL ANALYSIS OF THC IN HUMANS (01)$120,941
M01 · FY2007 · RR · contact PI
A Pharmacological Analysis of Delta 9-THC in Humans$149,880
K01 · FY2006 · DA · contact PI
A PHARMACOLOGICAL ANALYSIS OF THC IN HUMANS (01)$91,949
M01 · FY2006 · RR · contact PI
A Pharmacological Analysis of Delta 9-THC in Humans$130,601
K01 · FY2005 · DA
MONOAMINE TRANSPORTERS IN ANIMAL MODELS OF COCAINE ABUSE$33,980
F31 · FY2001 · DA
MONOAMINE TRANSPORTERS IN ANIMAL MODELS OF COCAINE ABUSE$31,280
F31 · FY2000 · DA